Search results
EU approves Sanofi's Dupixent for 'smoker's lungs' - ET HealthWorld | Pharma
The Economic Times· 12 hours agoThe EU Commission approved Dupixent to treat chronic obstructive pulmonary disease (COPD) in...
EU approves Sanofi's Dupixent for 'smoker's lungs'
The Economic Times· 14 hours agoThe EU Commission approved Dupixent to treat chronic obstructive pulmonary disease (COPD) in patients that cannot be helped by standard inhaled drugs,...
All You Need to Know About Asbestos Floor Tiles
Bob Vila· 4 days agoWhen asbestos fibers are inhaled, they lodge in the lungs and do not break down, which can lead to illness. The primary diseases related to asbestos...
Verona scores FDA approval for Ohtuvayre as COPD maintenance therapy
Pharmaceutical Technology· 6 days agoOhtuvayre is an inhaled dual inhibitor of phosphodiesterase 3 and phosphodiesterase 4 enzymes and...
FDA approves new COPD drug developed by firm in Raleigh. First new treatment in a decade
Durham Herald-Sun· 6 days agoFirst, it is a bronchodilator, opening airways in the lungs to make breathing easier. Second, it is...
Hampton Chocolate Factory Sells A 5-Pound Ice Cream Cone (But Why?)
Mashed· 3 days agoMeanwhile, someone who has already surpassed such feats of eating might simply treat it more like a...
Why Is My Cat Sneezing So Much? Veterinarians Weigh In With Potential Causes
First for Women· 2 days agoForeign object Excessive sneezing can also be a sign that your cat has a foreign object irritating...
7 Ways to Prevent Car Sickness If Long Rides Always Make You Queasy
Self· 2 days agoOne study found that people who slowed their breathing rate to about eight times a minute had fewer...
How dragons, magic and steamy sex took over the book world
Livemint· 3 days agoIn the literary genre known as romantasy—a mix of fantasy and romance—heroines ride dragons to...
15 Hours in the Halifax Airport: A Blizzard-Bound Food Diary
Conde Nast Traveler· 5 days agoWe were still delayed by a few unlikely hours. “It’s comin’ down some bad out there,” said a man at...